![]() |
市場調查報告書
商品編碼
2107866
腹部主動脈血管瘤修復器材市場:依產品類型、最終用戶和地區分類Abdominal Aortic Aneurysm Repair Devices Market, By Product Type, By End user, By Geography |
||||||
預計到 2026 年,腹部主動脈血管瘤修復器材市場規模將達到 31.2 億美元,到 2033 年將達到 45.8 億美元。預計 2026 年至 2033 年的複合年成長率將達到 5.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年: | 2025 | 2026年市場規模: | 31.2億美元 |
| 歷史數據時期: | 2020年至2024年 | 預測期: | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率: | 5.60% | 2033年市場規模預測: | 45.8億美元 |
該市場正經歷穩定成長,主要原因是人口老化導致腹部主動脈血管瘤盛行率不斷上升、微創血管內動脈瘤修復術的日益普及、動脈瘤篩檢計畫的擴展以及主動脈血管支架系統的持續技術進步。
腹部主動脈血管瘤修復裝置用於隔離、加固或修復腹主動脈的薄弱或擴張部分。該市場包括腹主動脈血管支架、導引鞘、導管、血管成形球囊、導管導引線以及其他用於血管內和開放式動脈瘤修復的手術附件。
由於血管內動脈瘤修復術具有微創、恢復時間短、住院時間短以及適用於某些老年和高風險患者等優點,醫療專業人員擴大採用該術式。此外,低輪廓輸送系統、移植物適應性、固定機制、密封技術和模組化裝置設計的進步,使醫生能夠處理更廣泛的血管解剖結構。
開窗式和分支式血管支架系統的日益普及,為位於腎動脈或內臟動脈附近的複雜解剖結構動脈瘤患者提供了更多治療選擇。此外,人工智慧、自動化CT血管造影術分析和個人化手術計畫的整合,正在改善動脈瘤評估、器械尺寸選擇、封鎖區評估和術前規劃。
由於腹部主動脈血管瘤診斷數量的增加、系統性篩檢和監測計畫的擴展以及對微創血管手術的日益青睞,全球腹部主動脈血管瘤修復設備市場正在加速發展。
人口老化是影響市場成長的主要因素之一。老年人罹患腹部主動脈血管瘤的風險更高,導致需要定期後續觀察、血管外科醫師評估以及計畫內或緊急手術的患者人數增加。
血管內動脈瘤修復術的日益普及推動了腹部血管支架及相關手術器械的需求。與傳統開放性手術相比,血管內手術可透過較小的血管網路基地台進行,從而減輕手術帶來的身體負擔並縮短恢復時間,因此越來越受到合格的患者的青睞。
血管支架系統的技術進步也正在加速市場發展。製造商正致力於開發低輪廓導引器系統、提高移植物柔軟性、增強密封性能、改進固定方式、提供更廣泛的尺寸選擇,以及能夠適應短、彎曲、狹窄、鈣化或迂曲血管解剖結構的裝置。
混合手術室、先進血管造影術和影像設備、血管外科計畫以及專業主動脈治療中心的擴建,正在推動醫療機構的需求。醫院仍然是腹部主動脈血管瘤修復的主要最終用戶,因為該手術需要經驗豐富的血管外科醫生、先進的影像系統、麻醉支援、重症監護設施、血庫以及緊急開放性手術的能力。
然而,該市場面臨許多挑戰,例如先進血管支架系統高成本、存在內漏和移植物移位的風險、血管通路相關併發症、監管要求嚴格以及術後需要長期後續觀察。此外,部分患者在血管內動脈瘤修復術後可能需要二次手術。
持續的監管監督和上市後監測有助於收集有關器械耐久性、動脈瘤擴張、移植物移位、內漏、閉塞、破裂、轉為開放性手術以及動脈瘤相關死亡率的長期臨床證據。這有望提高產品質量,並增強醫生對先進修復系統的信心。
Abdominal Aortic Aneurysm Repair Devices Market is estimated to be valued at USD 3.12 Bn in 2026 and is expected to reach USD 4.58 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.12 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 4.58 Bn |
The market is experiencing steady growth, mainly driven by the rising prevalence of abdominal aortic aneurysms among the aging population, increasing adoption of minimally invasive endovascular aneurysm repair procedures, expansion of aneurysm screening programs, and continued technological advancements in aortic stent-graft systems.
Abdominal aortic aneurysm repair devices are used to isolate, reinforce, or repair weakened and enlarged sections of the abdominal aorta. The market includes abdominal aortic stent grafts, introducer sheaths, catheters, angioplasty balloons, guidewires, and other procedural accessories used during endovascular and open aneurysm repair procedures.
Healthcare providers are increasingly adopting endovascular aneurysm repair due to its minimally invasive nature, shorter recovery period, reduced hospital stay, and suitability for selected elderly and high-risk patients. Advancements in lower-profile delivery systems, graft conformability, fixation mechanisms, sealing technologies, and modular device designs are also enabling physicians to manage a wider range of vascular anatomies.
The increasing use of fenestrated and branched stent-graft systems is expanding treatment opportunities for patients with anatomically complex aneurysms located near the renal and visceral arteries. In addition, the integration of artificial intelligence, automated CT angiography analysis, and patient-specific procedural planning is improving aneurysm assessment, device sizing, sealing-zone evaluation, and preoperative planning.
The Global Abdominal Aortic Aneurysm Repair Devices Market is gaining momentum due to the increasing diagnosis of abdominal aortic aneurysms, expansion of organized screening and surveillance programs, and rising preference for minimally invasive vascular procedures.
Population aging represents one of the major factors influencing market growth. Older adults have a higher risk of developing abdominal aortic aneurysms, thereby increasing the number of patients requiring routine surveillance, vascular-surgeon assessment, and elective or emergency repair procedures.
The growing adoption of endovascular aneurysm repair is supporting demand for abdominal stent grafts and associated procedural devices. Compared with conventional open surgical repair, endovascular procedures can be performed through smaller vascular access points and are increasingly preferred for eligible patients due to reduced procedural trauma and shorter recovery periods.
Technological advancements in stent-graft systems are also accelerating market development. Manufacturers are focusing on lower-profile introducer systems, improved graft flexibility, enhanced sealing performance, better fixation, wider sizing options, and devices designed for short, angulated, narrow, calcified, or tortuous vascular anatomies.
The expansion of hybrid operating rooms, advanced angiographic imaging facilities, vascular-surgery programs, and specialized aortic treatment centers is strengthening institutional demand. Hospitals remain the primary end users because abdominal aortic aneurysm repair requires experienced vascular specialists, advanced imaging systems, anesthesia support, intensive-care facilities, blood-bank access, and emergency open-surgery capabilities.
However, the market faces challenges associated with the high cost of advanced stent-graft systems, risk of endoleaks, graft migration, vascular-access complications, stringent regulatory requirements, and the need for long-term post-procedure surveillance. Some patients may also require secondary interventions following endovascular aneurysm repair.
Continued regulatory oversight and post-approval surveillance are encouraging manufacturers to generate long-term clinical evidence related to device durability, aneurysm enlargement, migration, endoleaks, occlusion, rupture, conversion to open surgery, and aneurysm-related mortality. This is expected to support product-quality improvements and strengthen physician confidence in advanced repair systems.